Core Viewpoint - The Hong Kong stock market continues its strong performance, with the Hang Seng Index rising by 2.58%, driven by positive market sentiment and significant inflows into various ETFs managed by GF Fund [1]. Group 1: Market Performance - The Hong Kong stock market's strong performance is reflected in the gains of nine ETFs under GF Fund, with the Hong Kong Innovative Drug ETF (513120) rising over 4.26%, and several other ETFs, including the China Concept Internet ETF (159605) and the Hang Seng Technology ETF Leader (513380), also showing gains exceeding 3% [1]. - The AH premium index has dropped to around 125%, nearing historical lows, which is attributed to continuous inflows from southbound funds and the attractiveness of high-dividend assets in the Hong Kong market [1]. Group 2: Investment Strategies - Huatai Securities' Hong Kong stock strategy team recommends focusing on sectors with improving sentiment and low valuations, particularly emphasizing technology stocks [2]. - The team suggests increasing allocations to internet e-commerce leaders ahead of the mid-August reporting period for overseas Chinese stocks, particularly those with good valuation and improving sentiment [2]. Group 3: ETF Product Overview - GF Fund's range of nine Hong Kong ETFs covers key sectors such as technology, innovative drugs, non-bank financials, and new consumption, catering to investors' needs for capturing market trends [3]. - The Hong Kong Innovative Drug ETF (513120) is the largest in the market, with a scale exceeding 18 billion, and has delivered over 100% returns this year [2]. - The Hong Kong Non-Bank ETF (513750) has also seen significant inflows, with a scale surpassing 13.7 billion, allowing for efficient investment in quality non-bank assets [2].

Group 1 - The logistics ETF (516910) leads the market with a gain of 3.56% [1] - The CSI 2000 ETF (563200) increased by 1.94% [1] - The Hang Seng ETF (159312) rose by 1.27% [1] Group 2 - The innovative drug ETF (159748) experienced the largest decline, falling by 2.78% [1] - The aerospace ETF (159208) decreased by 1.21% [1] - The Hong Kong Stock Connect innovative drug ETF (159570) dropped by 1.19% [1]

在4月18日至4月21日港股休市期间，港股通相关ETF却接连走高，多只相关产品溢价率飙升至10%以上。 除了港股通100ETF以外，港股通50ETF、恒生ETF港股通、港股国企ETF、恒生港股通ETF等多只ETF被炒作。其中，港股通50ETF、恒生ETF港股通的溢 价率在10%以上，港股国企ETF的溢价率超8%，恒生港股通ETF的溢价率超5%。 遭爆炒的背后 记者梳理发现，多只被爆炒的ETF基金规模不大。比如，港股通100ETF截至4月18日的基金份额为0.82亿份，流通规模约为0.96亿元。 为何在港股休市期间，港股相关ETF成为活跃游资爆炒的"靶点"？首先，港股休市期间，港股通相关ETF的申购通道关闭，港股无法交易，导致净值 (IOPV)无法更新。比如，港股通100ETF曾在4月15日发布公告称，为保护基金份额持有人的利益，保障基金平稳运作，根据各基金合同等法律文件相关规 定、港股通非交易日及境外主要投资市场节假日安排，易方达基金旗下部分基金因4月18日、4月21日为港股通非交易日及境外主要投资市场节假日将暂停 申购、赎回、转换、定期定额投资业务，并于4月22日恢复办理上述业务。 4月21日，港股通100 ...